Justine Bénevent

521 total citations
36 papers, 312 citations indexed

About

Justine Bénevent is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Toxicology. According to data from OpenAlex, Justine Bénevent has authored 36 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pediatrics, Perinatology and Child Health, 22 papers in Public Health, Environmental and Occupational Health and 7 papers in Toxicology. Recurrent topics in Justine Bénevent's work include Pregnancy and Medication Impact (18 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Pharmacovigilance and Adverse Drug Reactions (7 papers). Justine Bénevent is often cited by papers focused on Pregnancy and Medication Impact (18 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Pharmacovigilance and Adverse Drug Reactions (7 papers). Justine Bénevent collaborates with scholars based in France, Canada and Denmark. Justine Bénevent's co-authors include François Montastruc, Jean‐Louis Montastruc, Christine Damase‐Michel, Agnès Sommet, Isabelle Lacroix, Haleh Bagheri, Maryse Lapeyre‐Mestre, Geneviève Durrieu, Leila Chebane and Fabien Despas and has published in prestigious journals such as American Journal of Epidemiology, Psychopharmacology and European Journal of Cancer.

In The Last Decade

Justine Bénevent

31 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justine Bénevent France 11 100 92 45 45 45 36 312
Maya Berlin Israel 11 139 1.4× 146 1.6× 29 0.6× 90 2.0× 43 1.0× 38 444
Marie‐Noëlle Beyens France 11 123 1.2× 56 0.6× 106 2.4× 25 0.6× 64 1.4× 27 507
Sigal Kaplan Israel 10 90 0.9× 155 1.7× 52 1.2× 31 0.7× 27 0.6× 48 389
Pipasha Biswas United Kingdom 10 73 0.7× 89 1.0× 137 3.0× 13 0.3× 63 1.4× 15 528
Alicia B. Minns United States 11 85 0.8× 52 0.6× 28 0.6× 7 0.2× 87 1.9× 46 453
Supriya Malhotra India 10 18 0.2× 97 1.1× 53 1.2× 24 0.5× 35 0.8× 65 469
E. Rubio Spain 12 33 0.3× 200 2.2× 86 1.9× 13 0.3× 27 0.6× 58 555
Florelle Bellet France 9 62 0.6× 20 0.2× 90 2.0× 7 0.2× 52 1.2× 14 337
Michele Tari Italy 13 34 0.3× 78 0.8× 37 0.8× 3 0.1× 54 1.2× 26 615
B. Mahieu Belgium 7 44 0.4× 57 0.6× 7 0.2× 22 0.5× 21 0.5× 13 327

Countries citing papers authored by Justine Bénevent

Since Specialization
Citations

This map shows the geographic impact of Justine Bénevent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justine Bénevent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justine Bénevent more than expected).

Fields of papers citing papers by Justine Bénevent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justine Bénevent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justine Bénevent. The network helps show where Justine Bénevent may publish in the future.

Co-authorship network of co-authors of Justine Bénevent

This figure shows the co-authorship network connecting the top 25 collaborators of Justine Bénevent. A scholar is included among the top collaborators of Justine Bénevent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justine Bénevent. Justine Bénevent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beau, Anna‐Belle, Jingping Mo, Xavier Moisset, Justine Bénevent, & Christine Damase‐Michel. (2024). Systematic review of gabapentinoid use during pregnancy and its impact on pregnancy and childhood outcomes: A ConcePTION study. Therapies. 80(4). 378–416.
2.
Bénevent, Justine, et al.. (2024). Prescriptions of respiratory medications in children aged 0–10 years: A longitudinal drug utilization study in the POMME database. Respiratory Medicine. 232. 107741–107741. 1 indexed citations
3.
Montastruc, François, Fabrice Muscari, Ivan Tack, et al.. (2024). Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions. Therapies. 79(5). 553–558.
4.
Kjær, Susanne K., Anne Broe, Anton Pottegård, et al.. (2024). Maternal use of hormonal contraception and risk of childhood leukemia: A Scandinavian population-based cohort study. European Journal of Cancer. 215. 115168–115168.
5.
Bénevent, Justine, et al.. (2023). Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors. The Journal of Clinical Psychiatry. 84(4). 2 indexed citations
7.
Lacroix, Isabelle, et al.. (2023). Surveillance des médicaments chez les femmes enceintes : à propos du réseau Regards. Sages-Femmes. 22(6). 51–55. 1 indexed citations
8.
Bénevent, Justine, Anna‐Belle Beau, Agnès Sommet, et al.. (2022). First trimester pregnancy exposure to fosfomycin and risk of major congenital anomaly: a comparative study in the EFEMERIS database. Infection. 51(1). 137–146. 2 indexed citations
9.
Denuelle, Marie, et al.. (2022). Interactions between antiseizure medications and contraception: A study about the knowledge of patients and their specialist physicians. Epilepsy & Behavior. 129. 108627–108627. 6 indexed citations
10.
Damase‐Michel, Christine, et al.. (2022). Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?. Therapies. 78(2). 165–173. 5 indexed citations
11.
Bénevent, Justine, et al.. (2021). Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database. Drug Safety. 44(7). 787–796. 3 indexed citations
12.
Lacroix, Isabelle, Justine Bénevent, & Christine Damase‐Michel. (2020). Chloroquine and hydroxychloroquine during pregnancy: What do we know?. Therapies. 75(4). 384–385. 22 indexed citations
13.
Hurault‐Delarue, Caroline, et al.. (2020). Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database. Therapies. 76(3). 239–247. 13 indexed citations
14.
Bénevent, Justine, Caroline Hurault‐Delarue, Jean‐Louis Montastruc, et al.. (2019). Pharmacoepidemiology in pregnancy. Therapies. 74(2). 289–300. 14 indexed citations
15.
Montastruc, Jean‐Louis, Justine Bénevent, François Montastruc, et al.. (2018). What is pharmacoepidemiology? Definition, methods, interest and clinical applications. Therapies. 74(2). 169–174. 63 indexed citations
16.
Montastruc, François, Justine Bénevent, Vanessa Rousseau, et al.. (2018). Fluoroquinolones and aortic aneurysms: Which fluoroquinolones are at risk?. Archives of Cardiovascular Diseases Supplements. 11(1). 152–153. 1 indexed citations
17.
Damase‐Michel, Christine, et al.. (2018). In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database. International Journal of Pediatric Otorhinolaryngology. 113. 192–197. 11 indexed citations
18.
Bénevent, Justine, et al.. (2018). POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure. Drug Safety. 42(1). 45–54. 10 indexed citations
19.
Portolan, Ghyslaine, Sophie Gautier, Laurence Vanlemmens, et al.. (2018). Pregnancy outcomes in women exposed to cancer chemotherapy. Pharmacoepidemiology and Drug Safety. 27(12). 1302–1308. 9 indexed citations
20.
Bénevent, Justine, Emmanuelle Bondon‐Guitton, Geneviève Durrieu, et al.. (2017). A comparative study of QT prolongation with serotonin reuptake inhibitors. Psychopharmacology. 234(20). 3075–3081. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026